Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Bone|September 18, 2017
Effect of eplerenone on markers of bone turnover in patients with primary hyperparathyroidism - The randomized, placebo-controlled EPATH trialNicolas Verheyen, Martin R Grübler, Andreas Meinitzer, et al.Iscience|April 6, 2023
Association of branched-chain amino acids with mortality-the Ludwigshafen Risk and Cardiovascular Health (LURIC) studyAngela P Moissl, Stefan Lorkowski, Andreas Meinitzer, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|October 13, 2015
Plasma Parathyroid Hormone Is Independently Related to Nocturnal Blood Pressure in Hypertensive Patients: The Styrian Hypertension StudyNicolas D Verheyen, Katharina Kienreich, Martin Gaksch, et al.Journal of Hypertension|July 6, 2016
Parathyroid hormone, aldosterone-to-renin ratio and fibroblast growth factor-23 as determinants of nocturnal blood pressure in primary hyperparathyroidism: the eplerenone in primary hyperparathyroidism trialNicolas Verheyen, Astrid Fahrleitner-Pammer, Burkert Pieske, et al.Plos One|April 14, 2017
Relationship between bone turnover and left ventricular function in primary hyperparathyroidism: The EPATH trialNicolas Verheyen, Astrid Fahrleitner-Pammer, Evgeny Belyavskiy, et al.Clinical Chemistry and Laboratory Medicine|April 23, 2017
Low-grade inflammation and tryptophan-kynurenine pathway activation are associated with adverse cardiac remodeling in primary hyperparathyroidism: the EPATH trialNicolas Verheyen, Andreas Meinitzer, Martin Robert Grübler, et al.Journal of Clinical Hypertension (Greenwich, Conn.)|August 24, 2017
Plasma parathyroid hormone and cardiovascular disease in treatment-naive patients with primary hyperparathyroidism: The EPATH trialJulia Wetzel, Stefan Pilz, Martin R Grübler, et al.Plos One|August 17, 2016
Effects of Renal Denervation Documented in the Austrian National Multicentre Renal Denervation RegistryDavid Zweiker, Thomas Lambert, Clemens Steinwender, et al.Journal of Hypertension|July 24, 2019
Blood pressure changes after renal denervation are more pronounced in women and nondiabetic patients: findings from the Austrian Transcatheter Renal Denervation RegistryDavid Zweiker, Thomas Lambert, Clemens Steinwender, et al.Journal of Hypertension|April 12, 2016
Effect of eplerenone on parathyroid hormone levels in patients with primary hyperparathyroidism: results from the EPATH randomized, placebo-controlled trialAndreas Tomaschitz, Nicolas Verheyen, Andreas Meinitzer, et al.Pageof 3